Home
Interesting shortcuts
EFFRA Members' Perspectives
News Dashboard
Projects
Projects
Results, demos etc.
Results, demos etc.
Structured Wiki
Search
FoF and Made in Europe Partnership
Demonstrators, pilots, prototypes
Exploitable result(s)
Significant innovations and lessons learned, training aspects
Report - Video - Presentation - Publication....?
Project clusters
Company perspectives
Manufacturing future products
Manufacturing performance characteristics
Technologies and enablers
ICT performance characteristics
Standards and standardisation
Contribution of R&I projects to standardisation
Regulatory and policy aspects
Standards - other classifications
Business model aspects
Pathways
MiE SRIA R&I Priorities
MiE 25-27 Priorities (public consultation)
MiE KPIs
Relevant open calls
EU-Programme-Call
NACE code
EFFRA Organisations - members
EFFRA WG pointers
Pathways
Pathways
Project ideas
Project ideas
People & organisations
People
Organisations
portal@effra.eu
Visit the EFFRA website
Login
Projects
Fluently
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
Fluently
mapped on
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-HCO-2014
HCO-04-2014 Support for international infectious disease preparedness research
HCO-05-2014 Global Alliance for Chronic Diseases: prevention and treatment of type 2 diabetes
HCO-07-2014 ERA-NET: Establishing synergies between the Joint Programming on Neurodegenerative Diseases Research and Horizon 2020
HCO-08-2014 ERA-NET: Aligning national/regional translational cancer research programmes and activities
HCO-10-2014 ERA NET rare disease research implementing IRDiRC objectives
H2020-HCO-2015
HCO-06-2015 Global Alliance for Chronic Diseases. Prevention and treatment of lung diseases
HCO-11-2015 ERA NET Collaboration and alignment of national programmes and activities in the area of brain-related diseases and disorders of the nervous system
HCO-12-2015 ERA NET: Antimicrobial resistance
HCO-13-2015 ERA-NET: Cardiovascular disease
HCO-17-2015 Towards sustainability and globalisation of the Joint Programming Initiative on Neurodegenerative Diseases
H2020-IBA-SC1-CORONAVIRUS-2020-3
IBA-SC1-CORONAVIRUS-2020-3
H2020-IBA-SC1-GACD-2018
IBA-SC1-GACD-2018
H2020-PHC-2014-single-stage
PHC-15-2014 Clinical research on regenerative medicine
H2020-PHC-2014-two-stage
PHC-10-2014 Development of new diagnostic tools and technologies: in vitro devices, assays and platforms
PHC-13-2014 New therapies for chronic non-communicable diseases
PHC-17-2014 Comparing the effectiveness of existing healthcare interventions in the elderly
H2020-PHC-2015-single-stage_RTD
PHC-15-2015 Clinical research on regenerative medicine
H2020-PHC-2015-two-stage
PHC-11-2015 Development of new diagnostic tools and technologies: in vivo medical imaging technologies
PHC-14-2015 New therapies for rare diseases
PHC-16-2015 Tools and technologies for advanced therapies
PHC-18-2015 Establishing effectiveness of health care interventions in the paediatric population
H2020-SC1-2016-RTD
SC1-PM-09-2016 New therapies for chronic diseases
SC1-PM-11-2016-2017 Clinical research on regenerative medicine
H2020-SC1-2016-RTD-Zika
SC1-PM-22-2016 Addressing the urgent research gaps against the Zika virus and other emerging threats in Latin America
H2020-SC1-2017-Single-Stage-RTD
SC1-HCO-07-2017 Global Alliance for Chronic Diseases (GACD) prevention and management of mental disorders
SC1-PM-11-2016-2017 Clinical research on regenerative medicine
H2020-SC1-2017-Two-Stage-RTD
SC1-PM-08-2017 New therapies for rare diseases
SC1-PM-10-2017 Comparing the effectiveness of existing healthcare interventions in the adult population
H2020-SC1-2018-Single-Stage-RTD
SC1-BHC-04-2018 Rare Disease European Joint Programme Cofund
SC1-BHC-09-2018 Innovation platforms for advanced therapies of the future
SC1-BHC-16-2018 Global Alliance for Chronic Diseases (GACD) - Scaling-up of evidence-based health interventions at population level for the prevention and management of hypertension and/or diabetes
SC1-BHC-18-2018 Translational collaborative cancer research between Europe and the Community of Latin American and Caribbean States (CELAC)
SC1-BHC-23-2018 Novel patient-centred approaches for survivorship, palliation and/or end-of-life care
H2020-SC1-2018-Two-Stage-RTD
SC1-BHC-15-2018 New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID)
H2020-SC1-2019-Single-Stage-RTD
SC1-BHC-07-2019 Regenerative medicine: from new insights to new applications
SC1-HCO-15-2019 Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)
H2020-SC1-2019-Two-Stage-RTD
SC1-BHC-14-2019 Stratified host-directed approaches to improve prevention, treatment and/or cure of infectious diseases
H2020-SC1-PHE-CORONAVIRUS-2020
SC1-PHE-CORONAVIRUS-2020
H2020-SMEINST-1-2014
PHC-12-2014-1 Clinical research for the validation of biomarkers and/or diagnostic medical devices
H2020-SMEINST-1-2015
PHC-12-2015-1 Clinical research for the validation of biomarkers and/or diagnostic medical devices
H2020-SMEINST-1-2016-2017
SMEInst-05-2016-2017 Supporting innovative SMEs in the healthcare biotechnology sector
H2020-SMEINST-2-2014
PHC-12-2014 Clinical research for the validation of biomarkers and/or diagnostic medical devices
H2020-SMEINST-2-2015
PHC-12-2015 Clinical research for the validation of biomarkers and/or diagnostic medical devices
H2020-SMEINST-2-2016-2017
SMEInst-05-2016-2017 Supporting innovative SMEs in the healthcare biotechnology sector